Suppr超能文献

β2-微球蛋白和α1-微球蛋白作为巴尔干地方性肾病的标志物,这是一种全球性疾病。

Beta2-microglobulin and alpha1-microglobulin as markers of Balkan endemic nephropathy, a worldwide disease.

机构信息

Institute of Nephrology, Faculty of Medicine, Niš, Serbia.

出版信息

Ren Fail. 2011;33(2):176-83. doi: 10.3109/0886022X.2011.552152.

Abstract

BACKGROUND

Urine beta2-microglobulin (beta2-MG) was mainly used as a tubular marker of Balkan endemic nephropathy (BEN) but recently alpha1-microglobulin (alpha1-MG) was proposed for the diagnosis of BEN. In this study, the potential of urine beta2-MG, alpha1-MG, albumin, and total protein in the differentiation of BEN from healthy persons and patients with glomerulonephritis (GN) and nephrosclerosis (NS) was examined.

METHODS

This study involved 47 patients with BEN, 36 with GN, 11 with NS, 30 healthy subjects from BEN families, and 46 healthy subjects from non-BEN families.

RESULTS

In BEN patients area under the curve (AUC) for urine beta2-MG (0.828) and alpha1-MG (0.782) was higher than for urine albumin (0.740), but in GN patients AUC for urine protein (0.854) and albumin (0.872) was significantly higher than for the two low molecular weight proteins. AUC for all four urinary markers in NS patients was significantly lower than in BEN patients, ranging between 500 and 595. Median urine beta2-MG excretion in BEN patients was 17.5 times higher than in GN patients and 18.3 times higher than in controls; median alpha1-MG excretion was higher only 3.0 and 2.25 times, respectively. In the differentiation of BEN from healthy controls, beta2-MG had higher sensitivity and specificity at the cutoff levels (p < 0.001) than alpha1-MG (p < 0.05). In the differentiation of BEN from GN, beta2-MG was the best marker.

CONCLUSION

All four urinary markers can be used for the differential diagnosis of BEN, beta2-MG being the best. Like in aristolochic acid nephropathy, beta2-MG seems to be an early marker of tubular damage in BEN.

摘要

背景

尿β2-微球蛋白(β2-MG)主要用作巴尔干地方性肾病(BEN)的管状标志物,但最近α1-微球蛋白(α1-MG)被提议用于诊断 BEN。在这项研究中,检测了尿β2-MG、α1-MG、白蛋白和总蛋白在区分 BEN 与健康人以及肾小球肾炎(GN)和肾动脉硬化(NS)患者方面的潜力。

方法

本研究涉及 47 名 BEN 患者、36 名 GN 患者、11 名 NS 患者、30 名来自 BEN 家族的健康受试者和 46 名来自非 BEN 家族的健康受试者。

结果

在 BEN 患者中,尿β2-MG(0.828)和α1-MG(0.782)的曲线下面积(AUC)高于尿白蛋白(0.740),但在 GN 患者中,尿蛋白(0.854)和白蛋白(0.872)的 AUC 明显高于这两种低分子量蛋白。NS 患者所有四种尿标志物的 AUC 明显低于 BEN 患者,范围在 500 到 595 之间。BEN 患者的尿β2-MG 排泄中位数比 GN 患者高 17.5 倍,比对照组高 18.3 倍;α1-MG 排泄中位数仅高 3.0 和 2.25 倍。在 BEN 与健康对照组的区分中,β2-MG 在截定点(p<0.001)具有比α1-MG(p<0.05)更高的敏感性和特异性。在 BEN 与 GN 的区分中,β2-MG 是最佳标志物。

结论

所有四种尿标志物均可用于 BEN 的鉴别诊断,β2-MG 是最佳标志物。与马兜铃酸肾病一样,β2-MG 似乎是 BEN 肾小管损伤的早期标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验